Full Press Release Details
AC Immune ACI 35 030 Phase 1b 2a Trial Interim Data Confirm Consistent Safety And Potent Immunogenicity of Ptau Alzheimer s Vaccine in High Dose Cohort.
ACIU
AC Immune ACI 35 030 Phase 1b 2a Trial Interim Data Confirm Consistent Safety And Potent Immunogenicity of Ptau Alzheimer s Vaccine in High Dose Cohort
Key Takeaway: AC Immune ACI 35 030 Phase 1b 2a Trial Interim Data Confirm Consistent Safety And Potent Immunogenicity of Ptau Alzheimer s Vaccine in High Dose Cohort